Masashi Yokoya

8PUBLICATIONS
12CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesOrganic chemical synthesis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 25, 2025
A Promising Resveratrol Analogue Suppresses CSCs in Non-Small-Cell Lung Cancer via Inhibition of the ErbB2 Signaling Pathway.

Tanapon Soonthonsrima, Ismail Dwi Putra, Preeyaphan Phookphan

|Aug 28, 2024
A New Renieramycin T Right-Half Analog as a Small Molecule Degrader of STAT3.

Preeyaphan Phookphan, Satapat Racha, Masashi Yokoya

|Dec 22, 2023
Simplified Synthesis of Renieramycin T Derivatives to Target Cancer Stem Cells via β-Catenin Proteasomal Degradation in Human Lung Cancer.

Zin Zin Ei, Satapat Racha, Masashi Yokoya

|Jul 28, 2023
Light-Mediated Transformation of Renieramycins and Semisynthesis of 4'-Pyridinecarbonyl-Substituted Renieramycin-Type Derivatives as Potential Cytotoxic Agents against Non-Small-Cell Lung Cancer Cells.

Suwimon Sinsook, Koonchira Buaban, Iksen Iksen

|Jun 22, 2023
Simple Strategy for Benzo[g]chromene Synthesis via a Photochemical Intramolecular Cyclization Reaction.

Masashi Yokoya, Ryo Fujimoto, Tomoki Kato

|Mar 29, 2023
Novel Synthetic Derivative of Renieramycin T Right-Half Analog Induces Apoptosis and Inhibits Cancer Stem Cells via Targeting the Akt Signal in Lung Cancer Cells.

Korrakod Petsri, Masashi Yokoya, Satapat Racha

Pageof 2

Frequent Collaborators

3 joint publications

Naoki Saito

3 joint publications

Zin Zin Ei

3 joint publications

Pithi Chanvorachote

2 joint publications

Supakarn Chamni